Westside Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3
Closed -$878 1462
2026
Q1
$878 Hold
3
﹤0.01% 1400
2025
Q4
$1.05K Buy
+3
New +$1.01K ﹤0.01% 1381
2018
Q4
Sell
-77
Closed -$21.3K 732
2018
Q3
$21.3K Hold
77
0.01% 350
2018
Q2
$18.3K Sell
77
-5
-6% -$1.16K 0.01% 425
2018
Q1
$18K Sell
82
-1
-1% -$235 0.01% 406
2017
Q4
$19.2K Sell
83
-9
-10% -$1.92K 0.01% 415
2017
Q3
$17.5K Sell
92
-3
-3% -$571 0.01% 414
2017
Q2
$18.3K Sell
95
-700
-88% -$126K 0.01% 401
2017
Q1
$131K Buy
795
+200
+34% +$31.8K 0.06% 163
2016
Q4
$86.8K Buy
+595
New +$79.7K 0.06% 151

Other funds holding ELV

Westside Investment Management's ELV Position: Q2 2026 in Review

Westside Investment Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 3 shares — an estimated $878 sold.

Westside Investment Management first reported a position in ELV in Q4 2016 and held it in 10 quarters. The position peaked at $131K in Q1 2017. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Westside Investment Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Westside Investment Management sold 3 Elevance Health shares in Q2 2026, an estimated $878.
  • Westside Investment Management first reported a position in Elevance Health in Q4 2016 and held it in 10 quarters.
  • Westside Investment Management's Elevance Health position peaked at $131K in Q1 2017.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.